Earnings calendar

Alnylam Pharmaceuticals, Inc. (ALNY) earnings: date, estimates, results and stock reactions

Next earnings: Q4 FY2026 on 2027-02-11 (expected, before the open). EPS estimate 1.73, revenue estimate 1.52B.

Over the last 12 reports the stock moved 10.1% on average (either way), rising 3 times and falling 9. EPS beat estimates 9 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-10-2916.261.66+879.5%1.46B1.43B-29.0%
Q2 FY20262026-07-301.211.63-25.8%1.29B1.32B-28.3%
Q1 FY20262026-04-301.510.87+73.2%1.17B1.12B-1.7%
Q4 FY20252026-02-120.821.16-29.3%1.10B1.15B-2.4%
Q3 FY20252025-10-301.840.56+228.0%1.25B959.4M-5.3%
Q2 FY20252025-07-31-0.51-0.54+6.2%773.7M662.9M+18.2%
Q1 FY20252025-05-01-0.44-0.89+50.6%594.2M585.1M-1.5%
Q4 FY20242025-02-13-0.65-0.62-4.8%593.2M582.6M-3.6%

ALNY stock report · Earnings calendar